Academic article
-
Fedro Alessandro Peccatori; Giovanni Codacci-Pisanelli; Gunnar Mellgren
et al. (2020). First-in-human pharmacokinetics of tamoxifen and its metabolites in the milk of a lactating mother: A case study. (external link)
-
Thomas Helland; Kari Britt Hagen; Martha Eimstad Haugstøyl
et al. (2019). Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database. (external link)
-
Thomas Helland; Nina Henne; Ersilia Bifulco
et al. (2017). Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients. (external link)
-
Harriet Johansson; Sara Gandini; Davide Serrano
et al. (2016). A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen. (external link)
-
Thomas Helland; Jennifer Gjerde; Simon N Dankel
et al. (2015). The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells. (external link)
-
Monika Christensen; Ingvild Sveinsgjerd Fenne; Yngve Nordbø
et al. (2015). Novel inflammatory biomarkers in primary hyperparathyroidism. (external link)
-
Monika Christensen; Ingvild Sveinsgjerd Fenne; Marianne Hauglid Flågeng
et al. (2014). Estradiol determines the effects of PTH on ERα-dependent transcription in MC3T3-E1 cells. (external link)
-
Kari Britt Hagen; Turid Aas; Kirsten Lode
et al. (2014). Illness uncertainty in breast cancer patients: Validation of the 5-item short form of the Mishel Uncertainty in Illness Scale. (external link)
-
Tuyen Hoang; Ingvild Sveinsgjerd Fenne; Andre Greger Madsen
et al. (2013). cAMP response element-binding protein interacts with and stimulates the proteasomal degradation of the nuclear receptor coactivator GRIP1. (external link)
-
Davide Serrano; Matteo Lazzeroni; Sara Gandini
et al. (2013). A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer. (external link)
-
Monika Christensen; Ellen M Apalset; Yngve Nordbø
et al. (2013). 1,25-dihydroxyvitamin D and the vitamin D receptor gene polymorphism apa1 influence bone mineral density in primary hyperparathyroidism. (external link)
-
Ernst Asbjørn Lien; Håvard Søiland; Steinar Lundgren
et al. (2013). Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment. (external link)
-
Monika Christensen; Eva Kristine Ringdal Pedersen; Yngve Nordbø
et al. (2012). Vitamin B6 status and interferon-γ-mediated immune activation in primary hyperparathyroidism. (external link)
-
Line Leonore Haugan Moi; Marianne Hauglid Flågeng; Jennifer Gjerde
et al. (2012). Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer. (external link)
-
Jennifer Gjerde; Sara Gandini; Aliana Guerrieri-Gonzaga
et al. (2012). Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide. (external link)
-
Paal Methlie; Eystein Sverre Husebye; Simon Steinar Hustad
et al. (2011). Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease. (external link)
-
Andrea Decensi; Aliana Guerrieri-Gonzaga; Sara Gandini
et al. (2011). Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer. (external link)
-
Monika Christensen; Simon E Nitter Dankel; Yngve Nordbø
et al. (2011). Primary hyperparathyroidism influences the expression of inflammatory and metabolic genes in adipose tissue. (external link)
-
Monika Christensen; Ernst Asbjørn Lien; Simon Steinar Hustad
et al. (2010). Seasonal and age-related differences in serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone in patients from Western Norway. (external link)
-
Jennifer Gjerde; Jürgen Geisler; Steinar Lundgren
et al. (2010). Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer. (external link)
-
Line Leonore Haugan Moi; Marianne Hauglid Flågeng; Sara Gandini
et al. (2010). Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue. (external link)
-
MH Flageng; Marianne Hauglid; Line Leonore Haugan Moi
et al. (2009). Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors. (external link)
-
B Bonanni; D Serrano; S Gandini
et al. (2009). Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia. (external link)
-
Andrea Decensi; Chris Robertson; Aliana Guerrieri-Gonzaga
et al. (2009). Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women. (external link)
-
Timothy L Lash; Ernst Asbjørn Lien; Henrik Toft Sørensen
et al. (2009). Genotype-guided tamoxifen therapy: time to pause for reflection?. (external link)
-
Jennifer Fernandez Gjerde; Marianne Hauglid; M Hauglid
et al. (2008). Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism. (external link)
-
Elham Karimian; Andrei S Chagin; Jennifer Fernandez Gjerde
et al. (2008). Tamoxifen impairs both longitudinal and cortical bone growth in young male rats. (external link)
-
Ingvild Sveinsgjerd Fenne; Tuyen Hoang; Marianne Hauglid
et al. (2008). Recruitment of coactivator glucocorticoid receptor interacting protein 1 to an estrogen receptor transcription complex is regulated by the 3',5'-cyclic adenosine 5'-monophosphate-dependent protein kinase. (external link)
-
Jennifer Gjerde; Jurgen Geisler; Steinar Lundgren
et al. (2007). A study of association between estrogen and tamoxifen metabolism, cytochrome 2D6 and sulfotransferae 1A1 polymorphisms, and sulfotransferase 1A1 gene copy number during steady sate tamoxifen treatment. (external link)
-
J Geisler; Per Eystein Lønning; LE Krag
et al. (2006). Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: A randomised, placebo-controlled study. (external link)
-
Jan Schjøtt; Jennifer Gjerde; Elton Richard Kisanga
et al. (2006). Pretreatment with tamoxifen does not change acute epirubicin cardiotoxicity in rats. (external link)
-
Elton Richard Kisanga; Gunnar Mellgren; Ernst Asbjørn Lien
(2005). Excretion of hydroxylated metabolites of tamoxifen in human bile and urine. (external link)
-
Jennifer Fernandez Gjerde; Elton Richard Kisanga; Marianne Hauglid
et al. (2005). Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry. (external link)
-
Elton Richard Kisanga; Line Leonore Haugan Moi; Jennifer Gjerde
et al. (2005). Induction of hepatic drug-metabolising enzymes and tamoxifen metabolite profile in relation to administration route during low-dose treatment in nude rats. (external link)
-
Elton Richard Kisanga; Jennifer Gjerde; Aliana Guerrieri-gonzaga
et al. (2004). Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in randomized preoperative trial. (external link)
-
Simon Steinar Hustad; Bjørn Gunnar Nedrebø; Per Magne Ueland
et al. (2004). Phenotypic expression of the methylenetetrahydrofolate reductase 677C->T polymorphism and flavine cofactor availability in thyroid dysfunction. (external link)
-
Pål Ivar Holm; Øyvind Bleie; Per Magne Ueland
et al. (2004). Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation. (external link)
-
Tuyen Hoang; Ingvild Sveinsgjerd Fenne; Carol Ann Cook
et al. (2004). cAMP-dependent protein kinase regulates ubiquitin-proteasome-mediated degradation and subcellular localization of the nuclear receptor coactivator GRIP1. (external link)
-
A Decensi; C Robertson; G Viale
et al. (2003). A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers. (external link)
-
B Bonanni; H Johansson; S Gandini
et al. (2003). Effect of tamoxifen at low doses on ultrasensitive C-reactive protein in healty women. (external link)
-
Elton Richard Kisanga; Jennifer Gjerde; Jan Schjøtt
et al. (2003). Tamoxifen administration and metabolism in nude mice and nude rats. (external link)
-
Gunnar Mellgren; Bente Børud; Tuyen Thi Van Hoang
et al. (2003). Characterization of receptor-interacting protein RIP140 in the regulation of SF-1 responsive target genes. (external link)
-
Pål Ivar Holm; Per Magne Ueland; Gry Kvalheim
et al. (2003). Determination of choline, betaine, and dimethylglycine in plasma by a high-troughput metod based on normal-phase chromatography-tandem mass spectrometry. (external link)
-
Bjørn Gunnar Nedrebø; Steinar Hustad; Jørn Schneede
et al. (2003). Homocysteine and its relations to B-vitamins and smoking in graves' disease before and after treatment. (external link)
-
Gunnar Mellgren; Pål Ivar Holm; Ernst Asbjørn Lien
et al. (2002). Tyreotoksisk periodisk paralyse - en uvanlig komplikasjon ved hypertyreose. (external link)
-
Bjørn G Nedrebø; Pål Ivar Holm; Sverre Uhlving
et al. (2002). Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease. (external link)
-
Bjørn G Nedrebø; Ottar Nygård; Per Magne Ueland
et al. (2001). Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment. (external link)
-
Arve Ulvik; Espen Thiis Evensen; Ernst Asbjørn Lien
et al. (2001). Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum. (external link)
-
A Guerrieri-Gonzaga; L Baglietto; H Johansson
et al. (2001). Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trial. (external link)
-
B Bonanni; H Johansson; S Gandini
et al. (2001). Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women. (external link)
-
Ernst Asbjørn Lien; Per Eystein Lønning
(2000). Selective oestrogen receptor modifiers (SERMs) and breast cancer therapy. (external link)
-
Ernst Asbjørn Lien; Per Eystein Lønning
(2000). Selective oestrogen receptor modifiers (SERMs) and breast cancer therapy. (external link)
-
Ernst Asbjørn Lien; Bjørn Gunnar Nedrebø; Jan Erik Varhaug
et al. (2000). Plasma total homocysteine levels during short-term iatrogenic hypothyreoidism. (external link)
-
A Decensi; S Gandini; A Guerrieri-Gonzaga
et al. (1999). Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction. (external link)
-
RR Love; Gun Birgitta Anker; Y Yang
et al. (1999). Serum homocysteine levels in postmenopausal breast cancer patients treated with tamoxifen. (external link)
-
Gun Birgitta Anker; Helga Refsum; Per Magne Ueland
et al. (1999). Influence of aromatase inhibitors on plasma total homocysteine in postmenopausal breast cancer patients. (external link)
-
Gun Birgitta Anker; Helga Refsum; Per Magne Ueland
et al. (1999). Influence of aromatase inhibitors on plasma total homocysteine levels in postmenopausal breast cancer patients. (external link)
-
B.G. Nedrebø; U.-B. Ericsson; Ottar Nygård
et al. (1998). Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. (external link)
-
B.G. Nedrebø; U.-B. Ericsson; Ottar Nygård
et al. (1998). Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. (external link)
-
B.G. Nedrebø; U.-B. Ericsson; Ottar Nygård
et al. (1998). Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. (external link)
-
B.G. Nedrebø; U.-B. Ericsson; Ottar Nygård
et al. (1998). Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. (external link)
-
Gun Birgitta Anker; Asbjørn Aakvaag; Per Eystein Lønning
et al. (1998). Thyroid function in postmenopausal breast cancer patients treated with tamoxifen. (external link)
-
Gun Birgitta Anker; Per Eystein Lønning; Asbjørn Aakvaag
et al. (1998). Thyroid function in postmenopausal breast cancer patients treated with tamoxifen. (external link)
-
Gun Birgitta Anker; Per Eystein Lønning; Asbjørn Aakvaag
et al. (1998). Thyroid function in postmenopausal breast cancer patients treated with tamoxifen. (external link)
-
Ernst Asbjørn Lien; Gun Birgutta Anker; Per Eystein Lønning
et al. (1997). Effects of hormones on the plasma level of the atherogenic amino acid homocysteine. (external link)
-
Ernst Asbjørn Lien; O. Overå
(1997). Treatment of small cell lung cancer (SCLC) with high dose tamoxifen in combination with epirubicin, cyclophosphamide and oncovin. (external link)
-
Ernst Asbjørn Lien; Gun Birgitta Anker; Per Eystein Lønning
et al. (1997). Effects of hormones on the plasma levels of the atherogenic amino acid homocysteine. (external link)
-
Gun Birgitta Anker; Per Eystein Lønning; Per Magne Ueland
et al. (1995). Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen. (external link)
-
Per Eystein Lønning; Dag Clement Johannessen; Ernst Asbjørn Lien
et al. (1995). Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients. (external link)
-
Ernst Asbjørn Lien; Gun Birgitta Anker; Per Eystein Lønning
et al. (1995). Determination of droloxifene and two metabolites in serum by high-pressure liquid chromatography. (external link)
-
Per Eystein Lønning; Svein Inge Helle; Dag Clement Johannessen
et al. (1995). Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients. (external link)
-
Per Eystein Lønning; Dag Clement Johannesen; Svein Inge Helle
et al. (1995). Relations between sex hormones, sex hormone binding globulin insulin-like growth factor binding protein-1 in postmenopausal breast cancer patients. (external link)
-
Ernst Asbjørn Lien; Gun Birgitta Anker; Per Eystein Lønning
et al. (1995). Determination of droloxifene and two metabolites in serum by high pressure liquid chromatography. (external link)
-
Per Eystein Lønning; Svein Inge Helle; Dag Clement Johannesen
et al. (1995). Influence of tamoxifen on sex hormones, gonadotropins and sex hormone binding globulin in postmenopausal breast cancer patients. (external link)
-
Ernst Asbjørn Lien; Gun Birgitta Anker; Per Magne Ueland
(1995). Pharmacokinetics of tamoxifen in pre- and post-menopausal women with breast cancer. (external link)
-
Gun Birgitta Anker; Per Eystein Lønning; Per Magne Ueland
et al. (1995). Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen. (external link)
-
M. J. Millward; Ernst Asbjørn Lien; A. Robinson
et al. (1994). High-dose (480 mg/day) tamoxifen with etoposide: a study of a potential multi-drug resistance modulator. (external link)
-
Per Eystein Lønning; Ernst Asbjørn Lien
(1994). Pharmacokinetics of anti-endocrine agents. (external link)
-
Per Eystein Lønning; K. Hall; A. Aakvaag
et al. (1992). Influence of tamoxifen on plasma levels of insulinelike growth factor I and insulin-like growth factor binding protein I in breast cancer patients. (external link)
-
Ernst Asbjørn Lien; Dag Clement Johannessen; A. Aakvaag
et al. (1992). Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-1 levels in breast cancer patients. (external link)
-
Per Eystein Lønning; K. Hall; A. Aakvaag
et al. (1992). Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients. (external link)
-
Per Eystein Lønning; K. Hall; A. Aakvaag
et al. (1992). Influence of tamoxifen on plasma levels of IGF-I and IGFBP-I in breast cancer patients. (external link)
-
N. S. A. Stuart; P. Philip; A. L. Harris
et al. (1992). High dose tamoxifen as an enhancer of etoposide cytotoxicity.Clinical effects and in vitro assessment in p-glycoprotein expressing cell lines. (external link)
-
Ernst Asbjørn Lien; Dag Clement Johannessen; A. Aakvaag
et al. (1992). Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients. (external link)
-
Per Eystein Lønning; K. Hall; A. Aakvaag
et al. (1992). Influence of tamoxifen on plasma levels of IGF-I and IGFBP-I in breast cancer patients. (external link)
-
Ernst Asbjørn Lien; Dag Clement Johannessen; A. Aakvaag
et al. (1992). Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-1 levels in breast cancer patients. (external link)
-
Ernst Asbjørn Lien; D. C. Johannesen; A. Aakvaag
et al. (1992). Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-1 levels in breast cancer patients. (external link)
-
M. J. Milward; B. M. J. Cantwell; Ernst Asbjørn Lien
et al. (1992). Intermittent high dose tamoxifen as a potential modifier of multi-drug resistance. (external link)
-
Ernst Asbjørn Lien; E. Solheim; P. M. Ueland
(1991). Distribution of tamoxifen and its metabolites in tissues of rat and man during steady state treatment. (external link)
-
Ernst Asbjørn Lien; Knut Wester; Per Eystein Lønning
et al. (1991). Distribution of tamoxifen and metabolites into brain tissue metastases in breast cancer patients. (external link)
-
Ernst Asbjørn Lien; E. Solheim; P. M. Ueland
(1991). Distribution of tamoxifen and its metabolites in rat and human tissues during steady state treatment. (external link)
-
Ernst Asbjørn Lien; Knut Wester; Per Eystein Lønning
et al. (1991). Distribution of Tamoxifen and meta-bolites into brain tissue and brain metastases in brain cancer patients. (external link)
-
Ernst Asbjørn Lien; Knut Wester; Per Eystein Lønning
et al. (1991). Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients. (external link)
-
Ernst Asbjørn Lien; Gun Birgitta Anker; Per Eystein Lønning
et al. (1990). Decreased serum concentrations of tamoxifen and its metabolites induced by aminogluethimide. (external link)
Academic book chapter
Conference abstract
Conference lecture
Conference poster
Doctoral thesis (PhD)
Letter to the editor
Professional article
See a complete overview of publications in NVA.